Why Novavax Stock Is Bound for Massive Gains in 2021 : vimar

Why Novavax Stock Is Bound for Massive Gains in 2021
InvestorPlace
1/12/2021
© Source: Ascannio/Shutterstock.com
Novavax (NVAX) logo surrounded by medical supplies
Count
Novavax (NASDAQ:
NVAX) investors among the winners of 2020. At least those who got in early. The biotech company has spent the last decade focused on vaccine development, and that meant a payoff in 2020 when the desperate search for a novel coronavirus vaccine began. Novavax was among the companies on the hunt resulting in huge gains for NVAX stock. At its peak last August, NVAX was up 3,875% from the start of the year! Several companies ultimately beat Novavax to market with vaccines, and that had a cooling effect on the company’s shares.

Related Keywords

Mexico , Australia , New Zealand , Novavax Covid , Ascannio Shutterstock , Investorplace Novavax , Drug Administration , Tinto Stage , Fast Track , Operation Warp Speed , Inks Big Contracts , மெக்ஸிகோ , ஆஸ்திரேலியா , புதியது ஜீலாந்து , க்குள் நிலை , வேகமாக டிராக் , செயல்பாடு போரிடு வேகம் , மை பெரியது ஒப்பந்தங்கள் ,